Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Metadata
Title
Plasminogen activator system modulates invasivecapacity and proliferation in prostatic tumor cells
Authors
Claudio Festuccia
Vincenza Dolo
Fulvio Guerra
Stefania Violini
Paola Muzi
Antonio Pavan
Mauro Bologna
Publication date
01-08-1998
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 6/1998
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006590217724

Other articles of this Issue 6/1998

Clinical & Experimental Metastasis 6/1998 Go to the issue

OriginalPaper

Regulation of matrix metalloproteinase-2(gelatinase A, MMP-2), membrane-type matrixmetalloproteinase-1 (MT1-MMP) and tissue inhibitorof metalloproteinases-2 (TIMP-2) expression byelastin-derived peptides in human HT-1080 fibrosarcoma cell line

OriginalPaper

G-CSF increases secretion of urokinase-typeplasminogen activator by human lung cancer cells

OriginalPaper

Modulation of angiogenesis by human gliomaxenograft models that differentially express vascular endothelial growth factor

OriginalPaper

Comparison of 16 human colon carcinoma celllines for their expression of sialyl Le X antigens and their E-selectin-dependent adhesion

OriginalPaper

Platelet-derived growth factor (PDGF) BB acts as achemoattractant for human malignant mesotheliomacells via PDGF receptor b - integrin a3b1 interaction

OriginalPaper

Inhibition of tumor invasion and metastasis by calciumspirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits